EBioMedicine

Immune signals’ links to breast aging shift across menopause

In 81 women with biopsies 2–10 years apart, the same immune-related gene patterns were linked to slower breast tissue shrinkage across menopause but faster shrinkage afterward.

Fig. 1. Breast tissue that stalls at the menopausal transition retains a proliferation-competent epithelial state with tumour-associated gene expression.
Open the figure at full size
Fig. 1. Breast tissue that stalls at the menopausal transition retains a proliferation-competent epithelial state with tumour-associated gene expression.Breast tissue that stalls at the menopausal transition retains a proliferation-competent epithelial state with tumour-associated gene expression.Lue et al.

Our read

Mechanisms
Studied:
Cohort study of 81 women with paired benign breast biopsies, 2-10 years
What changed:
Higher immune signals were linked to slower breast lobule shrinkage during the menopausal transition, but faster shrinkage after menopause
The catch:
Registry-reported menopause age can misclassify women near the menopausal boundary
Stake:
An author holds patents licensed to Unity Biotechnology.
Why it’s aging research:
It studies something that builds up in the body with age.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

An observational study followed 81 women aged 45–55 at their first noncancerous breast biopsy, with a second biopsy 2–10 years later. Researchers measured gene activity and shrinkage of lobules, clusters of milk-producing glands.

Gene activity related to inflammatory signals from senescent cells—cells that stop dividing—and the body's built-in immune defenses showed opposite associations with shrinkage. These patterns were linked to slower shrinkage across the menopausal transition but faster shrinkage after menopause. Imaging in small subsets linked stalled shrinkage around menopause to immune cells positioned apart from cells carrying a protein associated with senescence. After menopause, a pattern associated with cell removal featured immune cells contacting those marked cells. The authors concluded that interpreting these biological signals should account for menopausal timing.

Why it matters

Incomplete shrinkage of breast lobules is associated with higher breast cancer risk. Understanding its relationship with immune activity may help researchers interpret tissue signals in the context of menopause.

Caveats

The observational design could not show that immune-cell contact caused cell removal or faster shrinkage. Imaging involved 14–16 women at baseline and 14 at follow-up; the findings concern noncancerous breast tissue.

From the paper

Participants

We analysed 81 women with paired benign biopsies (baseline age 45–55; follow-up 2–10 years) who had noninvoluted lobules at baseline.

Results, Menopausal timing is associated with how immune cells access p16⁺ epithelium during breast ageing

Quoted word for word from the full text on PubMed Central.

Comments

Be the first to comment.